RAND economists have a long and distinguished history of applying innovative research methods to improve health and the efficiency of health care service delivery.
With the help of a generous donation from former trustee Peter Bing, RAND created the Bing Center for Health Economics to continue to strengthen this tradition of innovative, high-profile research in health economics and health services.
To decrease excessive health care spending, the California Public Employees Retirement System incentivized patients to seek care from less expensive providers, reducing the "moral hazard" inherent with insurance coverage.
Biologics are complex drugs used to treat rheumatoid arthritis, cancer, and other diseases. They accounted for 70 percent of the growth in U.S. prescription drug spending between 2010 and 2015. Biosimilar versions of biologics could cut health care costs by $54 billion over the next decade.
To stabilize the state's individual health insurance market, Iowa proposed the Iowa Stopgap Measure (ISM). ISM modifications would increase the federal deficit, but decrease federal spending per enrollee.
RAND studied trends affecting U.S. cord blood banks and considered changes to improve banks' financial stability. Researchers found a system worthy of investment, especially if it helps improve the quality of the inventory.
Americans expect affordable coverage for pre-existing conditions, access to routine services, and protection from unpredictable and significant financial risk from accidents or illness. As a product designed primarily for risk protection, insurance may not be the most efficient or affordable approach to achieving all of these objectives.
Christine Eibner has been appointed to the RAND Corporation's Paul O'Neill Alcoa Chair in Policy Analysis, RAND President and CEO Michael D. Rich announced in May.
Eibner, who is based at RAND's office in Arlington, Virginia, will continue to work on modeling the nation's health care system and aiding policymakers as they consider proposals to improve affordability and extend coverage.
"Christine Eibner's research and analysis has provided objective, credible evidence to all stakeholders in the highly politicized debate over health care," Rich said. "Support from the Alcoa Chair will help her extend the impact of her research and analysis, stay ahead of the curve on emerging policy issues and mentor the next generation of policy researchers."
Over the past decade, Eibner has led numerous complex analyses that have had a major impact on the direction and contours of U.S. health care reform. She has led efforts to model the impacts of the federal Affordable Care Act, and had advised federal and state officials about the potential impacts of a wide array of health care policies.
Her research has been published in major health policy journals, including Health Affairs, Health Services Research and The New England Journal of Medicine. She is frequently cited in influential news media. Eibner, who received her Ph.D. in economics from the University of Maryland, received the 2016 AcademyHealth HSR Impact Award.
Marc Elliott Selected to Join AcademyHealth Methods Council
Marc Elliott has been chosen by AcademyHealth to join its Methods Council. The Council consists of 21 members who advise AcademyHealth leadership on priorities and trends in new methods and trainings for AcademyHealth members and the field of health services research.
Beau Kilmer Recognized for Innovation in Alcohol and Drug Policy Research
The U.S. Department of Transportation's National Highway Traffic Safety Administration (NHTSA) presented Beau Kilmer with a public service award in recognition of his leadership and innovation in the areas of alcohol and drug-impaired driving program and policy research. Kilmer's 24/7 Sobriety Program has been implemented in several states around the U.S.
Health Services Research (HSR) Names Engberg and Mehrotra Article among Five Most Cited Articles